HIV Citation List: April 29, 2011 - May 12, 2011

Pubmed citations

1. Armstrong, K.L., T.H. Lee, and M. Essex, Replicative Fitness Costs of Nonnucleoside Reverse Transcriptase Inhibitor Drug Resistance Mutations on HIV Subtype C. Antimicrobial Agents and Chemotherapy, 2011. 55(5): p. 2146-53; PMID[21402856].

[Pubmed], HIV_0429-051311.

2. Stelleralides a-C, Novel Potent Anti-HIV Daphnane-Type Diterpenoids from Stellera Chamaejasme L. Asada, Y., A. Sukemori, T. Watanabe, K.J. Malla, T. Yoshikawa, W. Li, K. Koike, C.H. Chen, T. Akiyama, K. Qian, K. Nakagawa-Goto, S.L. Morris-Natschke, and K.H. Lee. Organic Letters, 2011. [Epub ahead of print]; PMID[21561135].

[Pubmed], HIV_0429-051311.

3. Natural Substrate Concentrations Can Modulate the Prophylactic Efficacy of Nucleotide HIV Reverse Transcriptase Inhibitors. Garcia-Lerma, J.G., W. Aung, M.E. Cong, Q. Zheng, A.S. Youngpairoj, J. Mitchell, A. Holder, A. Martin, S. Kuklenyik, W. Luo, C.Y. Lin, D.L. Hanson, E. Kersh, C.P. Pau, A.S. Ray, J.F. Rooney, W.A. Lee, and W. Heneine. Journal of Virology, 2011. [Epub ahead of print]; PMID[21525346].

[Pubmed], HIV_0429-051311.

4. Inhibitors of Histone Deacetylases: Correlation Between Isoform Specificity and Reactivation of HIV-1 from Latently Infected Cells. Huber, K., G. Doyon, J. Plaks, E. Fyne, J.W. Mellors, and N. Sluis-Cremer. Journal of Biological Chemistry, 2011. [Epub ahead of print]; PMID[21531716].

[Pubmed], HIV_0429-051311.

5. Jain, S. and K.L. Rosenthal, The Gp41 Epitope, Qarvlavery, Is Highly Conserved and a Potent Inducer of Iga That Neutralizes HIV-1 and Inhibits Viral Transcytosis. Mucosal Immunology, 2011. [Epub ahead of print]; PMID[21525865].

[Pubmed], HIV_0429-051311.

6. Combination Anti-HIV Therapy with the Self-Assemblies of an Asymmetric Bolaamphiphilic Zidovudine/Didanosine Prodrug. Jin, Y., R. Xin, L. Tong, L. Du, and M. Li. Molecular Pharmacology, 2011. [Epub ahead of print]; PMID[21553876].

[Pubmed], HIV_0429-051311.

7. Novel 4,4-Disubstituted Piperidine-Based C-C Chemokine Receptor -5 Inhibitors with High Potency against Human Immunodeficiency Virus-1 and an Improved Human Ether-a-Go-Go Related Gene (Herg) Profile. Kazmierski, W.M., D. Anderson, C. Aquino, B. Chauder, M. Duan, R. Ferris, T. Kenakin, C. Koble, D. Lang, M. McIntyre, J. Peckham, C. Watson, P. Wheelan, A. Spaltenstein, M. Wire, A. Svolto, and M. Youngman. Journal of Medicinal Chemistry, 2011. [Epub ahead of print]; PMID[21539377].

[Pubmed], HIV_0429-051311.

8. Cyclin K Inhibits HIV-1 Gene Expression and Replication by Interfering with Cdk9-Cyclin T1 Interaction in Nef Dependent Manner. Khan, S.Z. and D. Mitra. Journal of Biological Chemistry, 2011. [EPUB AHEAD OF PRINT]; PMID[21555514].

[Pubmed], HIV_0429-051311.

9. Sesquiterpene and Norsesquiterpene Derivatives from Sanicula Lamelligera and Their Biological Evaluation. Li, X.S., X.J. Zhou, X.J. Zhang, J. Su, X.J. Li, Y.M. Yan, Y.T. Zheng, Y. Li, L.M. Yang, and Y.X. Cheng. Journal of Natural Products, 2011. [Epub ahead of print]; PMID[21561060].

[Pubmed], HIV_0429-051311.

10. The L76v Drug Resistance Mutation Decreases the Dimer Stability and Rate of Autoprocessing of HIV-1 Protease by Reducing Internal Hydrophobic Contacts. Louis, J.M., Y. Zhang, J.M. Sayer, Y.F. Wang, R.W. Harrison, and I.T. Weber. Biochemistry, 2011. [Epub ahead of print]; PMID[21446746].

[Pubmed], HIV_0429-051311.

11. Dibenzocyclooctadiene Lignans from the Fruits of Schisandra Rubriflora and Their Anti-HIV-1 Activities. Mu, H.X., X.S. Li, P. Fan, G.Y. Yang, J.X. Pu, H.D. Sun, Q.F. Hu, and W.L. Xiao. Journal of Asian Natural Products Research, 2011. 13(5): p. 393-399; PMID[21534036].

[Pubmed], HIV_0429-051311.

12. Tigliane-Type Diterpenoid Glycosides from Euphorbia Fischeriana. Pan, L.L., P.L. Fang, X.J. Zhang, W. Ni, L. Li, L.M. Yang, C.X. Chen, Y.T. Zheng, C.T. Li, X.J. Hao, and H.Y. Liu. Journal of Natural Products, 2011. [Epub ahead of print]; PMID[21534540].

[Pubmed], HIV_0429-051311.

13. Discovery of a Potent Peptidic Cyclophilin a Inhibitor Trp-Gly-Pro. Pang, X., M. Zhang, L. Zhou, F. Xie, H. Lu, W. He, S. Jiang, L. Yu, and X. Zhang. European Journal of Medicinal Chemistry, 2011. 46(5): p. 1701-1705; PMID[21396746].

[Pubmed], HIV_0429-051311.

14. Therapeutic Compounds: Patent Evaluation of Wo2011011652a1. Supuran, C.T. Expert Opinion on Therapeutic Patents, 2011. [Epub ahead of print]; PMID[21548842].

[Pubmed], HIV_0429-051311.

15. 4'-C-Methyl-2'-Deoxyadenosine and 4'-C-Ethyl-2'-Deoxyadenosine Inhibit HIV-1 Replication. Vu, B.C., P.L. Boyer, M.A. Siddiqui, V.E. Marquez, and S.H. Hughes. Antimicrobial Agents and Chemotherapy, 2011. 55(5): p. 2379-2389; PMID[21343443].

[Pubmed], HIV_0429-051311.

16. Antiviral Activity of Alpha-Helical Stapled Peptides Designed from the HIV-1 Capsid Dimerization Domain. Zhang, H., F. Curreli, X. Zhang, S. Bhattacharya, A.A. Waheed, A. Cooper, D. Cowburn, E.O. Freed, and A.K. Debnath. Retrovirology, 2011. 8(1): p. 28; PMID[21539734].

[Pubmed], HIV_0429-051311.

ISI Web of Knowledge citations:

17. Chemoenzymatic Total Synthesis of Potent HIV Rnase H Inhibitor (-)-1,3,4,5-Tetragalloylapiitol. Batwal, R.U., R.M. Patel, and N.P. Argade. Tetrahedron-Asymmetry, 2011. 22(2): p. 173-177; ISI[000288890800008].

[WOS], HIV_0429-051311.

18. Isolation and Structure of a Novel Peptide Inhibitor of HIV-1 Integrase from Marine Polychaetes. Elyakova, L.A., B.V. Vaskovsky, N.I. Khoroshilova, S.I. Vantseva, and Y.Y. Agapkina. Russian Journal of Bioorganic Chemistry, 2011. 37(2): p. 207-216; ISI[000289300000008].

[WOS], HIV_0429-051311.

19. Anti-HIV and Immunomodulation Activities of Cacao Mass Lignin-Carbohydrate Complex. Sakagami, H., M. Kawano, M.M. Thet, K. Hashimoto, K. Satoh, T. Kanamoto, S. Terakubo, H. Nakashima, Y. Haishima, Y. Maeda, and K. Sakurai. In Vivo, 2011. 25(2): p. 229-236; ISI[000289322500012].

[WOS], HIV_0429-051311.

20. Resistance of a Human Immunodeficiency Virus Type 1 Isolate to a Small Molecule Ccr5 Inhibitor Can Involve Sequence Changes in Both Gp120 and Gp41. Anastasopoulou, C.G., T.J. Ketas, R.S. Depetris, A.M. Thomas, P.J. Klasse, and J.P. Moore. Virology, 2011. 413(1): p. 47-59; ISI[000289334500006].

[WOS], HIV_0429-051311.

21. Exploration of Novel Medicinal Leads by Use of Natural Products Inhibiting Nuclear Export of Proteins as Scaffolds. Tamura, S. and N. Murakami. Journal of Synthetic Organic Chemistry Japan, 2011. 69(4): p. 393-402; ISI[000289590300005].

[WOS], HIV_0429-051311.

22. Design, Synthesis, and X-Ray Structure of Substituted Bis-Tetrahydrofuran (Bis-Thf)-Derived Potent HIV-1 Protease Inhibitors. Ghosh, A.K., C.D. Martyr, M. Steffey, Y.F. Wang, J. Agniswamy, M. Amano, I.T. Weber, and H. Mitsuya. Acs Medicinal Chemistry Letters, 2011. 2(4): p. 298-302; ISI[000289613200009].

[WOS], HIV_0429-051311.

23. HIV-1 Escape from the Ccr5 Antagonist Maraviroc Associated with an Altered and Less-Efficient Mechanism of Gp120-Ccr5 Engagement That Attenuates Macrophage Tropism. Roche, M., M.R. Jakobsen, J. Sterjovski, A. Ellett, F. Posta, B. Lee, B. Jubb, M. Westby, S.R. Lewin, P.A. Ramsland, M.J. Churchill, and P.R. Gorry. Journal of Virology, 2011. 85(9): p. 4330-4342; ISI[000289618600025].

[WOS], HIV_0429-051311.

24. Consistent Inhibition of Hiv-1 Replication in Cd4(+) T Cells by Acyclovir without Detection of Human Herpesviruses. McMahon, M.A., T.L. Parsons, L. Shen, J.D. Siliciano, and R.F. Siliciano. Journal of Virology, 2011. 85(9): p. 4618-4622; ISI[000289618600057].

[WOS], HIV_0429-051311.

25. Alizarine Derivatives as New Dual Inhibitors of the HIV-1 Reverse Transcriptase-Associated DNA Polymerase and Rnase H Activities Effective Also on the Rnase H Activity of Non-Nucleoside Resistant Reverse Transcriptases. Esposito, F., T. Kharlamova, S. Distinto, L. Zinzula, Y.C. Cheng, G. Dutschman, G. Floris, P. Markt, A. Corona, and E. Tramontano. FEBS Journal, 2011. 278(9): p. 1444-1457; ISI[000289627800009].

[WOS], HIV_0429-051311.

26. Antiviral Propierties of 5,5 '-Dithiobis-2-Nitrobenzoic Acid and Bacitracin against T-Tropic Human Immunodeficiency Virus Type 1. Lara, H.H., L. Ixtepan-Turrent, E.N. Garza-Trevino, S.M. Flores-Tevino, G. Borkow, and C. Rodriguez-Padilla. Virology Journal, 2011. 8; ISI[000289652900001].

[WOS], HIV_0429-051311.

27. Synthesis, Biological Evaluation and Molecular Modeling Studies of Quinolonyl Diketo Acid Derivatives: New Structural Insight into the HIV-1 Integrase Inhibition. Vandurm, P., A. Guiguen, C. Cauvin, B. Georges, K. Le Van, C. Michaux, C. Cardona, G. Mbemba, J.F. Mouscadet, L. Hevesi, C. Van Lint, and J. Wouters. European Journal of Medicinal Chemistry, 2011. 46(5): p. 1749-1756; ISI[000289655100033].

[WOS], HIV_0429-051311.

28. Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design. Meanwell, N.A. Journal of Medicinal Chemistry, 2011. 54(8): p. 2529-2591; ISI[000289697800001].

[WOS], HIV_0429-051311.

29. Novel HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors: A Patent Review (2005-2010). Zhan, P. and X.Y. Liu. Expert Opinion on Therapeutic Patents, 2011. 21(5): p. 717-796; ISI[000289730600006].

[WOS], HIV_0429-051311.